News Sentiment

XSPRAY sentiment intelligence

Xspray Pharma AB (publ) news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 52 Balanced news tone 8 relevant articles
Exchange STO Sweden
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 14.94 Week of 10 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

81/100 classification confidence.

Company focus 8

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.6% over one week, -1.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

FDA puts the brakes on Xspray Pharma's Nilopki approval

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 81/100 classification
One-week reaction -2.6% Price reacting lower
Trend fit Trend inactive -1.3% over four weeks
Fair value -62.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 7
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 8
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Biostock 4
TradingView 2
simplywall.st 1
Fierce Pharma 1

Event Lens

What the news is about

Classified themes
Market update 6
Regulatory and legal 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-8 of 8